Literature DB >> 30355787

ABIN2 Function Is Required To Suppress DSS-Induced Colitis by a Tpl2-Independent Mechanism.

Sambit K Nanda1, Tsunehisa Nagamori1, Mark Windheim1, Sylvia Amu2, Gabriella Aviello2, Janet Patterson-Kane3, J Simon C Arthur4, Steven C Ley5, Padraic Fallon2, Philip Cohen6.   

Abstract

The A20-binding inhibitor of NF-κB 2 (ABIN2) interacts with Met1-linked ubiquitin chains and is an integral component of the tumor progression locus 2 (Tpl2) kinase complex. We generated a knock-in mouse expressing the ubiquitin-binding-defective mutant ABIN2[D310N]. The expression of Tpl2 and its activation by TLR agonists in macrophages or by IL-1β in fibroblasts from these mice was unimpaired, indicating that the interaction of ABIN2 with ubiquitin oligomers is not required for the stability or activation of Tpl2. The ABIN2[D310N] mice displayed intestinal inflammation and hypersensitivity to dextran sodium sulfate-induced colitis, an effect that was mediated by radiation-resistant cells rather than by hematopioetic cells. The IL-1β-dependent induction of cyclooxygenase 2 (COX2) and the secretion of PGE2 was reduced in mouse embryonic fibroblasts and intestinal myofibroblasts (IMFs) from ABIN2[D310N] mice. These observations are similar to those reported for the Tpl2 knockout (KO) mice (Roulis et al. 2014. Proc. Natl. Acad. Sci. USA 111: E4658-E4667), but the IL-1β-dependent production of COX2 and PGE2 in mouse embryonic fibroblasts or IMFs was unaffected by pharmacological inhibition of Tpl2 in wild-type mice. The expression of ABIN2 is decreased drastically in Tpl2 KO mice. These and other lines of evidence suggest that the hypersensitivity of Tpl2 KO mice to dextran sodium sulfate-induced colitis is not caused by the loss of Tpl2 catalytic activity but by the loss of ABIN2, which impairs COX2 and PGE2 production in IMFs by a Tpl2 kinase-independent pathway.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30355787      PMCID: PMC6350896          DOI: 10.4049/jimmunol.1700614

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis.

Authors:  Seth Rakoff-Nahoum; Justin Paglino; Fatima Eslami-Varzaneh; Stephen Edberg; Ruslan Medzhitov
Journal:  Cell       Date:  2004-07-23       Impact factor: 41.582

2.  Phosphorylation at Thr-290 regulates Tpl2 binding to NF-kappaB1/p105 and Tpl2 activation and degradation by lipopolysaccharide.

Authors:  Jeonghee Cho; Philip N Tsichlis
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

3.  MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts.

Authors:  Giselle R Wiggin; Ana Soloaga; Julia M Foster; Victoria Murray-Tait; Philip Cohen; J Simon C Arthur
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

4.  Polyubiquitin binding to optineurin is required for optimal activation of TANK-binding kinase 1 and production of interferon β.

Authors:  Catherine E Gleason; Alban Ordureau; Robert Gourlay; J Simon C Arthur; Philip Cohen
Journal:  J Biol Chem       Date:  2011-08-23       Impact factor: 5.157

5.  A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice.

Authors:  I Okayasu; S Hatakeyama; M Yamada; T Ohkusa; Y Inagaki; R Nakaya
Journal:  Gastroenterology       Date:  1990-03       Impact factor: 22.682

6.  The antiinflammatory endothelial tyrosine kinase Tie2 interacts with a novel nuclear factor-kappaB inhibitor ABIN-2.

Authors:  David P Hughes; Marie B Marron; Nicholas P J Brindle
Journal:  Circ Res       Date:  2003-02-27       Impact factor: 17.367

7.  Regulation of experimental autoimmune encephalomyelitis by TPL-2 kinase.

Authors:  Srividya Sriskantharajah; Eva Gückel; Niki Tsakiri; Katrin Kierdorf; Christine Brender; Abduelhakem Ben-Addi; Marc Veldhoen; Philip N Tsichlis; Brigitta Stockinger; Anne O'Garra; Marco Prinz; George Kollias; Steven C Ley
Journal:  J Immunol       Date:  2014-03-17       Impact factor: 5.422

8.  Polyubiquitin binding to ABIN1 is required to prevent autoimmunity.

Authors:  Sambit K Nanda; Ram K C Venigalla; Alban Ordureau; Janet C Patterson-Kane; David W Powell; Rachel Toth; J Simon C Arthur; Philip Cohen
Journal:  J Exp Med       Date:  2011-05-23       Impact factor: 14.307

9.  TPL2-mediated activation of ERK1 and ERK2 regulates the processing of pre-TNF alpha in LPS-stimulated macrophages.

Authors:  Simon Rousseau; Matoula Papoutsopoulou; Antony Symons; Dorthe Cook; John M Lucocq; Alan R Prescott; Anne O'Garra; Steven C Ley; Philip Cohen
Journal:  J Cell Sci       Date:  2008-01-15       Impact factor: 5.285

10.  Two phases of inflammatory mediator production defined by the study of IRAK2 and IRAK1 knock-in mice.

Authors:  Eduardo Pauls; Sambit K Nanda; Hilary Smith; Rachel Toth; J Simon C Arthur; Philip Cohen
Journal:  J Immunol       Date:  2013-08-05       Impact factor: 5.422

View more
  4 in total

Review 1.  Tumor progression locus 2 (TPL2) in tumor-promoting Inflammation, Tumorigenesis and Tumor Immunity.

Authors:  Lucy Wanjiru Njunge; Andreanne Poppy Estania; Yao Guo; Wanqian Liu; Li Yang
Journal:  Theranostics       Date:  2020-07-09       Impact factor: 11.556

2.  ULK1/2 Restricts the Formation of Inducible SINT-Speckles, Membraneless Organelles Controlling the Threshold of TBK1 Activation.

Authors:  Vera Vivian Saul; Markus Seibert; Marcus Krüger; Sylvia Jeratsch; Michael Kracht; Michael Lienhard Schmitz
Journal:  iScience       Date:  2019-08-06

3.  Distinct signals and immune cells drive liver pathology and glomerulonephritis in ABIN1[D485N] mice.

Authors:  Sambit Kumar Nanda; Tsvetana Petrova; Francesco Marchesi; Marek Gierlinski; Momchil Razsolkov; Katherine L Lee; Stephen W Wright; Vikram R Rao; Philip Cohen; J Simon C Arthur
Journal:  Life Sci Alliance       Date:  2019-11-06

Review 4.  Kinase inhibition in autoimmunity and inflammation.

Authors:  Ali A Zarrin; Katherine Bao; Patrick Lupardus; Domagoj Vucic
Journal:  Nat Rev Drug Discov       Date:  2020-10-19       Impact factor: 84.694

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.